Literature DB >> 10334766

Prediction of cardiovascular risk. Program is not suitable for diabetic patients.

A Zambanini, M R Smith, M D Feher.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10334766      PMCID： PMC1115793     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Lipid modification and coronary heart disease in type 2 diabetes: different from the general population?

Authors:  M D Feher; R S Elkeles
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

2.  Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.

Authors:  I U Haq; L E Ramsay; W W Yeo; P R Jackson; E J Wallis
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

3.  A simple computer program for guiding management of cardiovascular risk factors and prescribing.

Authors:  A D Hingorani; P Vallance
Journal:  BMJ       Date:  1999-01-09

4.  Gambling with cardiovascular risk: picking the winners and the losers.

Authors:  S Grover
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

5.  Dysglycaemia and risk of cardiovascular disease.

Authors:  H C Gerstein; S Yusuf
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

6.  Cholesterol reduction yields clinical benefit: impact of statin trials.

Authors:  A L Gould; J E Rossouw; N C Santanello; J F Heyse; C D Furberg
Journal:  Circulation       Date:  1998-03-17       Impact factor: 29.690

7.  Management of raised blood pressure in New Zealand: a discussion document.

Authors:  R Jackson; P Barham; J Bills; T Birch; L McLennan; S MacMahon; T Maling
Journal:  BMJ       Date:  1993-07-10

8.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

9.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

Review 10.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321
  10 in total
  1 in total

1.  PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.

Authors:  Nizal Sarrafzadegan; Razieh Hassannejad; Hamid Reza Marateb; Mohammad Talaei; Masoumeh Sadeghi; Hamid Reza Roohafza; Farzad Masoudkabir; Shahram Oveisgharan; Marjan Mansourian; Mohammad Reza Mohebian; Miquel Angel Mañanas
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.